CopyMark Law Group
4.9/5
Drawing for AMORLITE

USPTO serial 74501100

AMORLITE

Reviewed by CopyMark Law Group

Reg. 2127509Status 710
Filing date
Status date
Registration date
Jan 6, 1998
Examiner
CHARLON, BARNEY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with AMORLITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ronald J. Baron

RONALD J BARON HOFFMANN & BARON350 JERICHO TPKEJERICHO, NY 11753UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005medicinal matrix preparations for human, livestock and domestic animal use, namely antacids, antitussives, antihistamines, decongestants, alkaloids, mineral and nutritional supplements, mineral and nutritional additives, laxatives, vitamins, anti-cholesterolemics, antiarrhythmics, antipyretics, analgesics, appetite suppressants, cough suppressants, cough expectorants, mucolytics, anti-inflammatories, coronary dilators, cerebral dilators, peripheral vasodilators, anti-infectives, psychotropics, antimanics, stimulants for the treatment or stimulation of the cardiac system, cerebral system, central nervous system, genitals, hepatic system, intestinal system, respiratory system, spinal system, stomachic system, topical system, uterine system, and vascular system; sedatives, vasodilators, vasoconstrictors, antibiotics, tranquilizers, antipsychotics, anticoagulants, hypnotics, antiemetics, anti-nauseants, anticonvulsants, hyperglycemics and hypoglycemics, diuretics, antispasmodics, uterine relaxants, anabolics, antiasthmatics, mucolytics, anti-uricemics, antiuremics, antilipemics, pharmaceutical preparations for the treatment of gastrointestinal disorders or conditions, ulcer, diarrhea, anginal disorders or conditions, anxiety, migraine condition, benign or malignant tumors, hypertension, thrombosis, uricacidemia, neuromuscular conditions or disorders, obesity, disorders or conditions affecting the thyroid, pharmaceutical preparations for promoting erythropoiesisSECTION 8 - CANCELLED—
030sugar and preparations made from confectionery, namely candy, pastry, frozen confections, chocolate-based or custard-based fillings for chocolates, chocolate-based or custard-based fillings for chocolate candies, chocolate-based or custard-based fillings for candy bars, frostings, icings, and fondantSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2004C8..CANCELLED SEC. 8 (6-YR)—
Jan 6, 1998R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 14, 1997CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 14, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 1996CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 26, 1996DOCKASSIGNED TO EXAMINER—
Dec 19, 1996SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 24, 1996IUAFUSE AMENDMENT FILED—
Aug 1, 1996EX1GSOU EXTENSION 1 GRANTED—
Apr 17, 1996EXT1SOU EXTENSION 1 FILED—
Oct 24, 1995NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 1, 1995PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 1995NPUBNOTICE OF PUBLICATION—
Apr 11, 1995CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 27, 1995CNEAEXAMINER'S AMENDMENT MAILED—
Jan 12, 1995CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 19, 1994CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 1994CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Frequently asked questions

Related guidance